Inspector To Industry Consultant: Gert Bos, Face And Voice Of EU Notified Bodies, Leaves BSI
This article was originally published in Clinica
Gert Bos, one of the highest-profile representatives for EU notified bodies, is leaving BSI to work for industry as executive director and partner at Netherlands-headquartered Qserve Group, Clinica has learnt. In his new role, which starts on Jan. 1, Bos will be supporting Qserve’s global regulatory, clinical and quality team that works out of the EU, US and China.
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.